Diazepam

CAS 439-14-5 8 current records 3 historicalSmall Molecule

Who holds supplier records for Diazepam? 8 organisations hold a current record for Diazepam: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Italy (2), United States (1) and China (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Diazepam: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/diazepam

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Diazepam expires 10 Jun 2042. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Diazepam. Country is the organisation's recorded country, not necessarily the manufacturing site.

India3Italy2United States1China1Country not recorded for 1
Need Diazepam sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Diazepam, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
R.L. FINE CHEM PRIVATE LIMITED ChikkaballapurIN
CEP 2019-264 - Rev 03
Diazepam
Sept 2026—
HUAZHONG PHARMACEUTICAL CO., LTD. XiangyangCN
CEP 2024-536 - Rev 00
Diazepam
Dec 2025—
RUSAN PHARMA LTD MumbaiIN
CEP 2024-260 - Rev 00
Diazepam
Oct 2025—
CENTAUR PHARMACEUTICALS PRIVATE LIMITED MumbaiIN
CEP 2008-195 - Rev 05
Diazepam
Oct 2023—
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
R1-CEP 2003-272 - Rev 03
Diazepam
Apr 2023—
LAKE CHEMICALS PRIVATE LIMITED Shivaji NagarIN
R0-CEP 2020-376 - Rev 00
Diazepam
Nov 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Diazepam are no longer active. These show a past filing, not current supply.

Show all 3 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (47 listed products contain Diazepam). The latest listed patent expires 10 Jun 2042. The latest listed exclusivity runs to 15 Apr 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Diazepam is a benzodiazepine that enhances the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, producing sedative and anxiolytic effects. It is commonly used to treat anxiety, muscle spasms, and seizures.

Chemical identity

IUPAC name
7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one
Canonical SMILES
CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
InChIKey
AAOVKJBEBIDNHE-UHFFFAOYSA-N
Synonyms
Valium API, diazepam, Valium, Ansiolisina, Diazemuls, Apaurin, Faustan, Relanium, Seduxen, Sibazon, Stesolid, Bialzepam

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Benzodiazepine
Chemical structure
Benzodiazepines

Therapeutic areas

Anxiety DisordersMuscle SpasmsSeizure Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Diazepam?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Diazepam: CENTAUR PHARMACEUTICALS PVT LTD (India), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), R L Fine Chem Pvt. Ltd. (India), CAMBREX PROFARMACO MILANO SRL (Italy), NAVINTA LLC (United States), LAKE CHEMICALS PRIVATE LTD, RUSAN PHARMA LTD (India) and HUAZHONG PHARMACEUTICAL CO., LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Diazepam Drug Master Files are active?

CENTAUR PHARMACEUTICALS PVT LTD (DMF 21860), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 3164), R L Fine Chem Pvt. Ltd. (DMF 33858), CAMBREX PROFARMACO MILANO SRL (DMF 1478) and NAVINTA LLC (DMF 38844). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Diazepam records mean?

3 organisations have only inactive Type II DMFs for Diazepam. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Diazepam have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Diazepam on the EDQM register, including R.L. FINE CHEM PRIVATE LIMITED Chikkaballapur (IN), HUAZHONG PHARMACEUTICAL CO., LTD. Xiangyang (CN), RUSAN PHARMA LTD Mumbai (IN), CENTAUR PHARMACEUTICALS PRIVATE LIMITED Mumbai (IN), F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore (IT) and LAKE CHEMICALS PRIVATE LIMITED Shivaji Nagar (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Diazepam?

Yes. The latest patent listed for an approved US product containing Diazepam expires 10 Jun 2042, across 47 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Diazepam supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Diazepam?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.